Also interesting in that article is the prospect of use of PV-10 to treat liver cancers. Only a very small study was cited, but we should probably keep an eye on it as a potential alternative to SIRT.
Sorafenib and age factor., page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
-0.003(1.39%) |
Mkt cap ! $75.34M | |||
| Open | High | Low | Value | Volume |
| 17.8¢ | 17.8¢ | 17.5¢ | $2.762K | 15.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7394872 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2047452 | 32 |
View Market Depth
| Last trade - 13.06pm 04/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |